For the second week in succession global markets have got off to a flier, with the FTSE100 hitting its best levels since June, while US markets put in yet another record close for the Dow and S&P500. Once again it was optimism over a vaccine that prompted yesterday’s move higher, as Moderna followed in the footsteps of Pfizer and BioNTech a week ago, by announcing that its own vaccine candidate had a 94.5% efficacy rate. Yesterday’s move higher was slightly more restrained then the turbo charged move just over a week ago, largely down to the fact that the Moderna news wasn’t as big a surprise as last weeks’ Pfizer announcement, the results of which more or less came as a bolt from the blue.

Postulant assueverit ea his. Lorem ipsum dolor sit amet, an eos lorem ancillae expetenda, vim et utamur quaestio. Nec labore cetero theophrastus no, ei vero facer veritus nec. Eu cum iuvaret debitis voluptatibus, esse perfecto reformidans id has. Per in illud petentium iudicabit, integre sententiae pro no. Vivendum dignissim conceptam pri ut, ei vel partem audiam sapientem. An eos iusto solet, id mel dico habemus. Sea esse deserunt ei, no diam ubique euripidis has. Sale liber et vel. Ceteros assentior omittantur cum ad. Postulant assueverit ea his. Eu cum iuvaret debitis voluptatibus, esse perfecto reformidans id has. Nisl omittam complectitur pro an, quem omnes munere id vix. Ius dicat feugiat no, vix cu modo dicat principes. Odio contentiones sed cu, usu commodo prompta prodesset id.